JP7882859B2 - 薬剤用量ガイダンスに関連するシステム、デバイスおよび方法 - Google Patents

薬剤用量ガイダンスに関連するシステム、デバイスおよび方法

Info

Publication number
JP7882859B2
JP7882859B2 JP2023547060A JP2023547060A JP7882859B2 JP 7882859 B2 JP7882859 B2 JP 7882859B2 JP 2023547060 A JP2023547060 A JP 2023547060A JP 2023547060 A JP2023547060 A JP 2023547060A JP 7882859 B2 JP7882859 B2 JP 7882859B2
Authority
JP
Japan
Prior art keywords
dose
meal
user
guidance
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023547060A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024505285A5 (cg-RX-API-DMAC7.html
JP2024505285A (ja
Inventor
エー ヘイター,ゲイリー
バタチャリヤ,アパラジタ
エス ブディマン,アーウィン
ティー ノヴァク,マシュー
ジン,タイハオ
ビー タウブ,マーク
エム ファーン,ジョナサン
シュィ,ヨンジン
ジュー,カイユエン
コヴィントン,ケンダル
クック,ケリー
ローズ フレー,ジェシカ
ボスコ,ロジーナ
エム チャールズワース,テイラー
パルタサラティ,ヴィシュナヴィ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Diabetes Care Inc
Original Assignee
Abbott Diabetes Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Diabetes Care Inc filed Critical Abbott Diabetes Care Inc
Publication of JP2024505285A publication Critical patent/JP2024505285A/ja
Publication of JP2024505285A5 publication Critical patent/JP2024505285A5/ja
Application granted granted Critical
Publication of JP7882859B2 publication Critical patent/JP7882859B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Primary Health Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Data Mining & Analysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2023547060A 2021-02-03 2022-02-02 薬剤用量ガイダンスに関連するシステム、デバイスおよび方法 Active JP7882859B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163145131P 2021-02-03 2021-02-03
US63/145,131 2021-02-03
US202163225140P 2021-07-23 2021-07-23
US63/225,140 2021-07-23
US202163237769P 2021-08-27 2021-08-27
US63/237,769 2021-08-27
PCT/US2022/014920 WO2022169856A1 (en) 2021-02-03 2022-02-02 Systems, devices, and methods relating to medication dose guidance

Publications (3)

Publication Number Publication Date
JP2024505285A JP2024505285A (ja) 2024-02-05
JP2024505285A5 JP2024505285A5 (cg-RX-API-DMAC7.html) 2025-02-07
JP7882859B2 true JP7882859B2 (ja) 2026-06-30

Family

ID=80787465

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023547060A Active JP7882859B2 (ja) 2021-02-03 2022-02-02 薬剤用量ガイダンスに関連するシステム、デバイスおよび方法

Country Status (5)

Country Link
EP (1) EP4288970A1 (cg-RX-API-DMAC7.html)
JP (1) JP7882859B2 (cg-RX-API-DMAC7.html)
AU (1) AU2022216248A1 (cg-RX-API-DMAC7.html)
CA (1) CA3205053A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022169856A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4424234A4 (en) * 2021-10-25 2025-10-01 Medtrum Tech Inc CLOSED-LOOP ARTIFICIAL PANCREATIC INSULIN INFUSION CONTROL SYSTEM
CN121263852A (zh) * 2023-04-11 2026-01-02 威尔德康股份有限公司 用于连续葡萄糖监测结果预测的系统和方法
US12251242B1 (en) 2023-10-24 2025-03-18 UpDoc Inc. Voice-based method and system for management of type 2 diabetes
WO2025165721A1 (en) 2024-01-30 2025-08-07 Abbott Diabetes Care Inc. Systems and methods for diabetes management
WO2025193785A1 (en) * 2024-03-13 2025-09-18 Abbott Diabetes Care Inc. Antihyperglycemic methods and systems

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019118531A2 (en) 2017-12-12 2019-06-20 Bigfoot Biomedical, Inc. Therapy assist information and/or tracking device and related methods and systems
WO2021005552A1 (en) 2019-07-09 2021-01-14 El Fathi Anas Method and system for determining glucose change in a subject

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
EP1918837A1 (en) * 2006-10-31 2008-05-07 F. Hoffmann-La Roche AG Method for processing a chronological sequence of measurements of a time dependent parameter
EP4434458A3 (en) 2010-03-24 2024-12-18 Abbott Diabetes Care, Inc. Medical device inserters
WO2014018928A1 (en) 2012-07-27 2014-01-30 Abbott Diabetes Care Inc. Medical device applicators
US10383580B2 (en) 2012-12-31 2019-08-20 Abbott Diabetes Care Inc. Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
US9351670B2 (en) 2012-12-31 2016-05-31 Abbott Diabetes Care Inc. Glycemic risk determination based on variability of glucose levels
EP4420603A3 (en) 2013-03-15 2024-11-20 Abbott Diabetes Care, Inc. System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk
EP3125761B1 (en) 2014-03-30 2020-09-30 Abbott Diabetes Care Inc. Method and apparatus for determining meal start and peak events in analyte monitoring systems
EP4545005A3 (en) * 2016-01-14 2025-07-02 Insulet Corporation Adjusting insulin delivery rates
EP3568863A4 (en) 2017-01-11 2020-10-28 Abbott Diabetes Care Inc. EPISODE DETECTION AND EVALUATION SYSTEMS, DEVICES AND METHODS WITH VISITOR GUIDES AND ACTION PLANS
EP3570735A4 (en) 2017-01-23 2020-10-21 Abbott Diabetes Care Inc. SYSTEMS, DEVICES AND METHODS FOR INSERTING ANALYTE SENSOR
WO2018152241A1 (en) 2017-02-15 2018-08-23 Abbott Diabetes Care Inc. Systems, devices, and methods for integration of an analyte data reader and medication delivery device
WO2018156584A1 (en) 2017-02-21 2018-08-30 Abbott Diabetes Care Inc. Methods, devices, and systems for physiological parameter analysis
US11464459B2 (en) * 2017-12-12 2022-10-11 Bigfoot Biomedical, Inc. User interface for diabetes management systems including flash glucose monitor
CA3280266A1 (en) 2019-08-02 2025-10-30 Abbott Diabetes Care Inc. Systems, devices, and methods relating to medication dose guidance

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019118531A2 (en) 2017-12-12 2019-06-20 Bigfoot Biomedical, Inc. Therapy assist information and/or tracking device and related methods and systems
WO2021005552A1 (en) 2019-07-09 2021-01-14 El Fathi Anas Method and system for determining glucose change in a subject

Also Published As

Publication number Publication date
AU2022216248A1 (en) 2023-07-27
CA3205053A1 (en) 2022-08-25
WO2022169856A1 (en) 2022-08-11
JP2024505285A (ja) 2024-02-05
EP4288970A1 (en) 2023-12-13
AU2022216248A9 (en) 2025-01-30

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250130

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250130

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20251112

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251119

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260219

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260520

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260618

R150 Certificate of patent or registration of utility model

Ref document number: 7882859

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150